Assessment tools for peripheral neuropathy in pediatric oncology: a systematic review from the Children’s Oncology Group
| Autor: | Mary Ann Hensley, Lesley Arland, Suzanne Smolik, Debra Schissel, Barbara Shepperd, Cheryl Rodgers, Kristin M. Thomas |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
Vincristine Pediatrics medicine.medical_specialty Side effect Adolescent Drug-Related Side Effects and Adverse Reactions medicine.medical_treatment Nursing assessment Article 03 medical and health sciences 0302 clinical medicine Neoplasms medicine Pediatric oncology Humans Child Nursing Assessment Chemotherapy Oncology (nursing) business.industry Infant Newborn Infant Peripheral Nervous System Diseases medicine.disease Antineoplastic Agents Phytogenic Pediatric Nursing Pediatric patient Peripheral neuropathy Early Diagnosis 030220 oncology & carcinogenesis Child Preschool Disease Progression Female business 030217 neurology & neurosurgery Evidence synthesis medicine.drug |
| Popis: | Peripheral neuropathy is a known side effect of several chemotherapy agents, including vinca alkaloids and platinum-based chemotherapy. Early recognition and monitoring of this side effect is an important role of the pediatric oncology nurse. There are a variety of peripheral neuropathy assessment tools currently in use, but the usefulness of these tools in identifying and grading neuropathy in children varies, and there is currently no standardized tool in place to evaluate peripheral neuropathy in pediatric oncology. A systematic review was performed to identify the peripheral neuropathy assessment tools that best evaluate the early onset and progression of peripheral neuropathy in pediatric patients receiving vincristine. Because of the limited information available in pediatric oncology, this review was extended to any pediatric patient with neuropathy. A total of 8 studies were included in the evidence synthesis. Based on available evidence, the pediatric–modified Total Neuropathy Scale (ped-m TNS) and the Total Neuropathy Score–pediatric version (TNS-PV) are recommended for the assessment of vincristine-induced peripheral neuropathy in children 6 years of age and older. In addition, several studies demonstrated that subjective symptoms alone are not adequate to assess for vincristine-induced peripheral neuropathy. Nursing assessment of peripheral neuropathy should be an integral and regular part of patient care throughout the course of chemotherapy treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|